Beta blockers prove to treat heart failure at the brain level- not just directly in the heart. Very cool when you think about the implications.
Heart failure patients are routinely given beta-blockers, although doctors do not know exactly how these drugs boost cardiac performance and reduce the risk of death. The UCL study, based on the rat model of postmyocardial infarction-induced heart failure and published in the journal Circulation Research, has discovered that the beta-adrenoceptor blocker metoprolol acts directly in the brain to slow the progression of heart failure. The action seems to be localised to a group of brain cells that UCL researchers have identified previously as being crucial in the control of blood pressure and heart rate.
Will this provide more research to examine treating other cardiac disease at the central nervous system level? I think so. Here is to the future of cardiac medication- absolutely amazing!
via Univ College London
Tags: beta-blockers, heart-disease, heart-failureShare This
